Companies / OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc.

Nasdaq: OKURCIK 1637715BOULDER, CO

Financials · FY2024

Revenue$0
Net income$-59.52M
Total debt—
Cash$166.50M
Diluted EPS$-4.40
Shares outstanding40.5M

Ownership

40.5M shares outstanding · as of Aug 3, 2026
0.15%Insiders
Ownership
Insiders0.15%59,226
10%+ / strategic1.55%626,593
Institutions47.92%19,406,550
Public float50.38%20,403,940

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Manke IsaacDirector
0.05%20,583
Leverone Jason A.Chief Financial Officer
0.04%16,000
Mathers Edward TDirector
0.04%15,310
Saccomano Nicholas ACEOPresident and CEO · Director
0.02%7,333
Access Industries Holdings LLC10% owner
——
Access Industries Management, LLC10% owner
——
AI Biotechnology LLC10% owner
——
Blavatnik Len10% owner
——
Grey Michael GDirector
——

Institutional holders 50

View all →
HolderValue% of shares
RA Capital Management, L.P.$16.55M9.87%
Acorn Capital Advisors, LLC$8.24M7.01%
Bvf INC/IL$8.19M4.89%
BlackRock, Inc.$6.84M3.70%
Adage Capital Partners Gp, L.L.C.$4.99M2.98%
ADAR1 Capital Management, LLC$2.94M2.50%
Prosight Management, LP$2.37M2.02%
Shay Capital LLC$2.26M1.93%
Rosalind Advisors, Inc.$2.12M1.80%
State Street Corporation$2.11M1.14%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 23, 2026Leverone Jason A.
Executive
SellClass A Common Stock$1.3K-301
-1.85%
16,000
0.04% of shares
low
Mar 23, 2026Saccomano Nicholas A
CEO
SellClass A Common Stock$357-86
-1.16%
7,333
0.02% of shares
low
Dec 31, 2025Manke Isaac
Director
GrantClass A Common Stock$0+5K
+34.31%
20,583
0.05% of shares
low
Dec 31, 2025Mathers Edward T
Director
GrantClass A Common Stock$0+4K
+34.31%
15,310
0.04% of shares
low
Jun 4, 2026Mathers Edward T
Director
GrantStock Option (right to buy)—+8K
7,650
0.02% of shares
low
Jun 4, 2026Grey Michael G
Director
GrantStock Option (right to buy)—+8K
7,650
0.02% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—626,593—
Citadel Advisors LLCPassive13G/A———
Highbridge Capital Management, LLCPassive13G/A———
ADAR1 Capital Management, LLCPassive13G———
RA Capital Management, L.P.Passive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
OKUR——68277Q105—